Hepatitis C drug: Costly cure

August 3, 2014 7:02 AM

20 0

A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than three million Americans.

In less than six months, prescriptions for Sovaldi have eclipsed all other Hepatitis C pills combined, according to new data from IMS Health. The prospect of a real cure, with fewer nasty side effects, is enticing thousands of patients to get treated for the first time. But clinical and commercial s...

Read more

To category page